REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07154290 updates: 1. completion date: 2030-06-24 → 2030-06-10 2. primary completion date: 2030-06-24 → 2030-06-10
Clinical trial NCT07154290 updates: 1. completion date: 2030-06-24 → 2030-06-10 2. primary completion date: 2030-06-24 → 2030-06-10
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical